These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12970341)

  • 1. Structural properties of Gerstmann-Straussler-Scheinker disease amyloid protein.
    Salmona M; Morbin M; Massignan T; Colombo L; Mazzoleni G; Capobianco R; Diomede L; Thaler F; Mollica L; Musco G; Kourie JJ; Bugiani O; Sharma D; Inouye H; Kirschner DA; Forloni G; Tagliavini F
    J Biol Chem; 2003 Nov; 278(48):48146-53. PubMed ID: 12970341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions.
    Ricchelli F; Buggio R; Drago D; Salmona M; Forloni G; Negro A; Tognon G; Zatta P
    Biochemistry; 2006 May; 45(21):6724-32. PubMed ID: 16716083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein.
    Fioriti L; Angeretti N; Colombo L; De Luigi A; Colombo A; Manzoni C; Morbin M; Tagliavini F; Salmona M; Chiesa R; Forloni G
    J Neurosci; 2007 Feb; 27(7):1576-83. PubMed ID: 17301166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V.
    Tagliavini F; Lievens PM; Tranchant C; Warter JM; Mohr M; Giaccone G; Perini F; Rossi G; Salmona M; Piccardo P; Ghetti B; Beavis RC; Bugiani O; Frangione B; Prelli F
    J Biol Chem; 2001 Feb; 276(8):6009-15. PubMed ID: 11087738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gerstmann-Sträussler-Scheinker disease amyloid protein polymerizes according to the "dock-and-lock" model.
    Gobbi M; Colombo L; Morbin M; Mazzoleni G; Accardo E; Vanoni M; Del Favero E; Cantù L; Kirschner DA; Manzoni C; Beeg M; Ceci P; Ubezio P; Forloni G; Tagliavini F; Salmona M
    J Biol Chem; 2006 Jan; 281(2):843-9. PubMed ID: 16286452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro.
    Tagliavini F; Prelli F; Verga L; Giaccone G; Sarma R; Gorevic P; Ghetti B; Passerini F; Ghibaudi E; Forloni G
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9678-82. PubMed ID: 8105481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Fiorini M; Ferrari S; Meade-White K; Barbieri I; Brocchi E; Ghetti B; Monaco S
    J Biol Chem; 2014 Feb; 289(8):4870-81. PubMed ID: 24398683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred.
    Giaccone G; Verga L; Bugiani O; Frangione B; Serban D; Prusiner SB; Farlow MR; Ghetti B; Tagliavini F
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9349-53. PubMed ID: 1357663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways.
    Natalello A; Prokorov VV; Tagliavini F; Morbin M; Forloni G; Beeg M; Manzoni C; Colombo L; Gobbi M; Salmona M; Doglia SM
    J Mol Biol; 2008 Sep; 381(5):1349-61. PubMed ID: 18619462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.
    Parchi P; Chen SG; Brown P; Zou W; Capellari S; Budka H; Hainfellner J; Reyes PF; Golden GT; Hauw JJ; Gajdusek DC; Gambetti P
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8322-7. PubMed ID: 9653185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.
    Tagliavini F; Prelli F; Ghiso J; Bugiani O; Serban D; Prusiner SB; Farlow MR; Ghetti B; Frangione B
    EMBO J; 1991 Mar; 10(3):513-9. PubMed ID: 1672107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.
    Piccardo P; Liepnieks JJ; William A; Dlouhy SR; Farlow MR; Young K; Nochlin D; Bird TD; Nixon RR; Ball MJ; DeCarli C; Bugiani O; Tagliavini F; Benson MD; Ghetti B
    Am J Pathol; 2001 Jun; 158(6):2201-7. PubMed ID: 11395398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
    Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele.
    Tagliavini F; Prelli F; Porro M; Rossi G; Giaccone G; Farlow MR; Dlouhy SR; Ghetti B; Bugiani O; Frangione B
    Cell; 1994 Nov; 79(4):695-703. PubMed ID: 7954833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
    Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred).
    Piccardo P; Seiler C; Dlouhy SR; Young K; Farlow MR; Prelli F; Frangione B; Bugiani O; Tagliavini F; Ghetti B
    J Neuropathol Exp Neurol; 1996 Nov; 55(11):1157-63. PubMed ID: 8939199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.
    Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of infectious, non-fibrillar and oligomeric prions from a genetic prion disease.
    Vanni I; Pirisinu L; Acevedo-Morantes C; Kamali-Jamil R; Rathod V; Di Bari MA; D'Agostino C; Marcon S; Esposito E; Riccardi G; Hornemann S; Senatore A; Aguzzi A; Agrimi U; Wille H; Nonno R
    Brain; 2020 May; 143(5):1512-1524. PubMed ID: 32303068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy.
    Pirisinu L; Nonno R; Esposito E; Benestad SL; Gambetti P; Agrimi U; Zou WQ
    PLoS One; 2013; 8(6):e66405. PubMed ID: 23826096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients.
    Bahadi R; Farrelly PV; Kenna BL; Kourie JI; Tagliavini F; Forloni G; Salmona M
    Am J Physiol Cell Physiol; 2003 Oct; 285(4):C862-72. PubMed ID: 12814912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.